These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8423463)

  • 1. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
    Sharief MK; Hentges R; Ciardi M; Thompson EJ
    J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.
    Sharief MK; Hentges R; Thompson EJ
    J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
    Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
    J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
    Sharief MK; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):169-74. PubMed ID: 8437006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
    Sivieri S; Ferrarini AM; Gallo P
    Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis.
    Sharief MK; Thompson EJ
    J Neuroimmunol; 1992 May; 38(1-2):27-33. PubMed ID: 1577950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum.
    Gallo P; Piccinno MG; Tavolato B; Sidén A
    J Neurol Sci; 1991 Feb; 101(2):227-32. PubMed ID: 1827837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB; Boctor FN; Tourtellotte WW
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
    Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
    J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin.
    Matejčíková Z; Mareš J; Sládková V; Svrčinová T; Vysloužilová J; Zapletalová J; Kaňovský P
    Mult Scler Relat Disord; 2017 May; 14():12-15. PubMed ID: 28619424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
    Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
    Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
    Fesenmeier JT; Whitaker JN; Herman PK; Walker DP
    J Neuroimmunol; 1991 Oct; 34(1):77-80. PubMed ID: 1716642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
    Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
    Kleine TO; Zwerenz P; Graser C; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.
    Ciusani E; Frigerio S; Gelati M; Corsini E; Dufour A; Nespolo A; La Mantia L; Milanese C; Massa G; Salmaggi A
    J Neuroimmunol; 1998 Feb; 82(1):5-12. PubMed ID: 9526840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
    Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
    J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
    Ott M; Demisch L; Engelhardt W; Fischer PA
    J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.